Regulators agree on Covid-19 vaccination adaptation plan
On June 30, representatives of regulatory authorities from around the world met to discuss the adaptation of the existing Covid-19 vaccines in response to new Omicron variants of concern.
by christian bundgaard, translated by catherine brett
Despite the fact that evidence examined by regulatory authorities around the world and the World Health Organization (WHO) suggests that the first generation of Covid-19 vaccines still protects against serious illness, hospitalization and death, the organizations are keeping a close eye on new variants.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Epidemiologist calls Pfizer's corona pill a "game changer"
For subscribers
Novavax vaccine recommended for approval for EU teenagers
For subscribers
